5.2.2014 | Mezinárodní spolupráce
A Belgian university team developed a recombinant Bovine Leukemia Virus (BLV) with attenuated phenotype and two specific mutations. Efficacy, persistence, safety and pathogenicity make this vaccine unique. The research team is looking for collaboration with companies interested in license agreement.
3.2.2014 | Mezinárodní spolupráce
A Dutch medical university has developed new method that uses exon skipping in ALK4 and ALK5 for treatment of muscular dystrophies and other disorders. They are interested in collaborations with pharmaceutical and biotech companies for researching and developing treatments for muscular dystrophy.
31.1.2014 | Mezinárodní spolupráce
A Spanish R&D public organization has developed nanoparticles functionalized by a carrier peptide that engages a molecule from the cell microtubule motor complex, being able to deliver a drug to its intracellular destination, enhancing its accumulation and increasing cell to cell spread.
29.1.2014 | Mezinárodní spolupráce
The Epigenetics division of a Belgian global supplier of innovative solutions to academia, pharmaceutical and biotechnology companies is looking for license agreements from academic laboratories and research organisations that can provide already developed research antibodies to new target proteins.
27.1.2014 | Mezinárodní spolupráce
A French biotechnology company specialized in the development of new genomics tools to assist (Limousine cattle) breeders for selecting the best animals offers its R&D expertise for breed/species organizations, industrial companies interested in genomics or R&D organizations for research projects that require integrating or expanding aspects of...
23.1.2014 | Mezinárodní spolupráce
Spanish cluster is seeking innovative technologies for the treatment and disinfection of water for technological cooperation.
6.12.2013 | Mezinárodní spolupráce
A UK manufacturer of consumer goods is searching for technologies for rapid identification of airborne microbial contamination, to genus level. Solutions must be at least as sensitive as the contact plate method but faster. They must be suitable for high volume manufacturing. The nature of the technology has no limitations. The type of...
4.12.2013 | Mezinárodní spolupráce
An Israeli clinical stage biotechnology company is looking for a partner to collaborate on developing its lead compound, a short peptide antagonist of CD28, for treatment of immune related diseases. The company is seeking to collaborate with service providers, academic researchers and clinical investigators in the fields of drug development...
2.12.2013 | Mezinárodní spolupráce
A research organization and a university from Spain, and two universities from Costa Rica have developed a Brucella vaccine expressing the fluorescent protein GFP. This modification maintains the vaccine properties but allows identification of vaccinated animals by ELISA, UV detection, fluorescence microscopy or PCR. This solves the issue of...
28.11.2013 | Mezinárodní spolupráce
A Dutch company is specialized in supercritical fluid processes for pharmaceutical formulation development and production. The on-site fully certified production and research facilities include CO2 based drying, extraction and purification technology. The available technologies enable to develop micronized powders, (co-)crystals and encapsulates...
Gate2Biotech - Biotechnologický portál - Vše o biotechnologiích na jednom místě.
ISSN 1802-2685
Tvorba webových stránek: CREOS CZ
© 2006 - 2025 Jihočeská agentura pro podporu inovačního podnikání o.p.s.
Zajímavé články s biotechnologickým obsahem:
DNA - Lidskou DNA má pohltit polární led
Zaměstnání - poptávky - Možnost zdarma publikovat poptávaná zaměstnání pro firmy a organizace
Viry by mohly pomoct se šlechtěním nových plodin
Buněčné váčky spiruliny pomohou s vývojem účinných vakcín